Patents by Inventor Matthew Jeremiah Misner
Matthew Jeremiah Misner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11726078Abstract: A device for rapid detection of a tuberculosis lipoarabinomannan (TB-LAM) is provided. The device includes a pre-concentrator unit for concentrating the TB-LAM comprising: an ion-exchange medium comprising one or more ligands configured to capture the TB-LAM from the source biological sample, wherein the captured-TB-LAM is eluted from the ion-exchange medium as an eluate comprising a concentrated form of TB-LAM; a cassette; a lateral flow assay unit disposed in the cassette; and an integration unit attached to the pre-concentrator unit and the cassette. The integration unit is configured to operatively couple and de-couple the pre-concentrator unit and the cassette. The pre-concentrator unit and the lateral flow assay unit disposed in the cassette are in a fluidic communication in a coupled form. The device for rapid detection of TB-LAM further comprises a dilutor unit.Type: GrantFiled: November 6, 2020Date of Patent: August 15, 2023Assignees: General Electric Company, Tokitae LLCInventors: Matthew Jeremiah Misner, Gregory Andrew Grossmann, Cathryn Ellen Olsen, John Richard Nelson, David Roger Moore, Paul Michael Smigelski, Jr., John Thomas Connelly, Benjamin David Grant, Bernhard Hans Weigl
-
Patent number: 11714084Abstract: A rapid detection method of a target biomolecule comprising an antigenic moiety is provided. The method includes providing a source biological sample comprising the target biomolecule; contacting the source biological sample to an ion-exchange medium; eluting the captured-target biomolecule from the ion-exchange medium as an eluate, and loading the eluate to a rapid diagnostic testing device comprising an antibody. The eluate comprises a concentrated form of the biomolecule in a solution having a salt concentration greater than 150 mM. A concentration of the target biomolecule in the eluate is in a range from about 2× to 25× compared to a concentration of the biomolecule in the source biological sample. The target biomolecule binds to the antibody under the salt concentration of greater than 150 mM. A device for rapid detection of target biomolecule is also provided.Type: GrantFiled: November 5, 2020Date of Patent: August 1, 2023Assignee: General Electric CompanyInventors: Matthew Jeremiah Misner, Gregory Andrew Grossmann, Cathryn Ellen Olsen, John Richard Nelson, Brian Christopher Bales, David Roger Moore, Paul Michael Smigelski, Jr.
-
Publication number: 20220340755Abstract: Multicomponent copolymers including two or more types of repeat units is presented. In one example, the multicomponent copolymer includes at least one repeat unit AC having a structure (I), at least one repeat unit DC having a structure (II), and at least one repeat unit BC having a structure (III) or (V). The multicomponent copolymer may be cross-linked via a cross-linking agent. A polymer blend including the multicomponent copolymer or a cross-linked copolymer and a second polymer is also provided. The multicomponent copolymer may be a random or a block copolymer. The structural units of the multicomponent copolymers provide improved, tunable properties, such as improved biocompatibility and hydrophilicity, protein fouling, and mechanical properties, to the copolymers and/or the membranes fabricated from the copolymers.Type: ApplicationFiled: July 5, 2022Publication date: October 27, 2022Inventors: David Moore, Matthew Jeremiah Misner, Hongyi Zhou, Patrick McCloskey, Matthew Rainka
-
Patent number: 11407897Abstract: Multicomponent copolymers including two or more types of repeat units is presented. In one example, the multicomponent copolymer includes at least one repeat unit AC having a structure (I), at least one repeat unit DC having a structure (II), and at least one repeat unit BC having a structure (III) or (V). The multicomponent copolymer may be cross-linked via a cross-linking agent. A polymer blend including the multicomponent copolymer or a cross-linked copolymer and a second polymer is also provided. The multicomponent copolymer may be a random or a block copolymer. The structural units of the multicomponent copolymers provide improved, tunable properties, such as improved biocompatibility and hydrophilicity, protein fouling, and mechanical properties, to the copolymers and/or the membranes fabricated from the copolymers.Type: GrantFiled: November 30, 2020Date of Patent: August 9, 2022Assignee: CYTIVA SWEDEN ABInventors: David Moore, Matthew Jeremiah Misner, Hongyi Zhou, Patrick McCloskey, Matthew Rainka
-
Patent number: 11399743Abstract: The systems and methods described herein provide a wearable sweat sensing device. The device includes a sweat patch component including a sweat biochemical sensor patch having a substrate defining a hole, at least one biochemical sensor, and a capture wick including a tip that extends through the hole, the capture wick configured to channel sweat across the at least one biochemical sensor. The sweat patch component further includes a wick downstream from the capture wick and separated from the capture wick by a gap, and electronic circuitry disposed against at least one face of the wick, wherein an electronic response of the electronic circuitry changes as sweat flows through the wick. The wearable sweat sensing device further includes an electronics module component configured to facilitate assessing hydration of a wearer based on signals from the at least one biochemical sensor and the electronic circuitry.Type: GrantFiled: June 17, 2019Date of Patent: August 2, 2022Assignee: General Electric CompanyInventors: Ralf Lenigk, Azar Alizadeh, Matthew Jeremiah Misner, Andrew Arthur Paul Burns, Richard Jeanluc St. Pierre
-
Patent number: 11311225Abstract: A system for monitoring medical conditions includes a conformable medical monitoring device that includes a first substrate layer, which includes an electronics module, many signal traces, and at least one electrode, such that one or more of the many signal traces electrically couple the at least one electrode to the electronics module. The conformable medical monitoring device includes a second substrate layer positioned over the electronics module, the first substrate layer, or any combination thereof to insulate the electronics module, the first substrate layer, or any combination thereof. The conformable medical monitoring device also includes a third substrate layer positioned over the second substrate layer, such that the third substrate layer reduces electromagnetic interference caused by a voltage pulse and includes an adjustable system coupled to the first substrate layer and that changes a position of the at least one electrode relative to the electronics module.Type: GrantFiled: July 3, 2018Date of Patent: April 26, 2022Assignee: General Electric CompanyInventors: Azar Alizadeh, Andrew A. Burns, Matthew Jeremiah Misner, Ralf Lenigk, Jeffrey Michael Ashe, Obi Aghogho, Nancy Cecelia Stoffel, Juha Virtanen, Otto Pekander, Timo Toivanen, Robert Santala
-
Publication number: 20220041976Abstract: A system for isolating a target molecule from a bioprocess fluid includes a single-use disposable separation device having a plurality of perimeter-bonded layers defining one or more mesofluidic channels of the separation device, wherein each layer includes a biocompatible polymer material, wherein the separation device is configured to separate at least a portion of particles from the bioprocess fluid to generate a substantially clarified bioprocess fluid, and a chromatography system fluidically coupled at the outflow of the separation device in a configuration for further processing the clarified bioprocess fluid.Type: ApplicationFiled: August 30, 2019Publication date: February 10, 2022Inventors: Matthew Jeremiah Misner, Rachel Marie Gettings, Christine Angela Morton, Erik Leeming Kvam, Jason William CASTLE, Anindya Kanti De, Jared Timothy Hale, Craig Patrick Galligan, Vincent Francis Pizzi
-
Patent number: 11173490Abstract: The present disclosure relates to a sample assessment device. By way of example, the sample assessment device may include a substrate including a sample application region; an amplification region comprising a plurality of amplification reagents; a waste region comprising an entrance fluidically coupled to the amplification region and extending away from the amplification region; and a detection region spaced apart from the amplification region. The sample assessment device may also include a valve coupled to the substrate and configured to separate the amplification region from the detection region in a closed configuration, wherein the amplification region and the valve are positioned on the sample assessment device between the sample application region and the detection region and wherein the sample assessment device is configured to permit lateral flow from the amplification region to the detection region when the valve is in an open configuration.Type: GrantFiled: July 16, 2018Date of Patent: November 16, 2021Assignees: University of Washington, Global Life Sciences Solutions Operations UK Ltd.Inventors: David Roger Moore, Matthew Jeremiah Misner, Andrew Arthur Paul Burns, Joshua Bishop, Lisa K. Lafleur, Maxwell Wheeler
-
Publication number: 20210322933Abstract: A hollow-fiber membrane is presented. The hollow fiber membrane, includes a copolymer including sulfone structural units having a formula (I) and zwitterion-functionalized structural units having a formula (II). Method of making the hollow-fiber membrane is also presented.Type: ApplicationFiled: June 30, 2021Publication date: October 21, 2021Inventors: Patrick Joseph McCloskey, Cathryn Ellen Olsen, Hongyi Zhou, Louisa Ruth Carr, Matthew Jeremiah Misner
-
Patent number: 11028359Abstract: A system for isolating a target molecule from a bioprocess fluid includes a single-use disposable separation device having a plurality of perimeter-bonded layers defining one or more mesofluidic channels of the separation device, wherein each layer includes a biocompatible polymer material, wherein the separation device is configured to separate at least a portion of particles from the bioprocess fluid to generate a substantially clarified bioprocess fluid, and a chromatography system fluidically coupled at the outflow of the separation device in a configuration for further processing the clarified bioprocess fluid.Type: GrantFiled: September 11, 2018Date of Patent: June 8, 2021Assignee: GLOBAL LIFE SCIENCES SOLUTIONS USA LLCInventors: Matthew Jeremiah Misner, Rachel Marie Gettings, Christine Angela Morton, Erik Leeming Kvam, Jason William Castle, Anindya Kanti De, Jared Timothy Hale, Craig Patrick Galligan, Vincent Francis Pizzi
-
Patent number: 10983119Abstract: A rapid diagnostic testing device for testing of a biological sample is provided. The device comprises a channeled construct, at least one lateral flow unit, and a cassette housing. The channeled construct is configured to receive a biological sample to form at least partially purified biological sample. The lateral flow unit is at least partially disposed in the cassette housing. The lateral flow unit comprises: a sample receiving zone, a conjugate zone and a detection zone. The sample receiving zone is operatively coupled to the channeled construct for receiving the partially purified biological sample comprising at least one analyte. The conjugate zone comprising a conjugate particle to bind the analyte is disposed adjacent to the first side of the sample receiving zone. The detection zone is disposed adjacent to the second side of the sample receiving zone and comprises at least one binding agent for detecting the analyte.Type: GrantFiled: January 9, 2017Date of Patent: April 20, 2021Assignees: GENERAL ELECTRIC COMPANY, TOKITAE LLCInventors: Bing Li, Matthew Jeremiah Misner, David Roger Moore, Kevin Paul Flood Nichols, David Cate, Matthew F Rosen
-
Publication number: 20210079220Abstract: Multicomponent copolymers including two or more types of repeat units is presented. In one example, the multicomponent copolymer includes at least one repeat unit AC having a structure (I), at least one repeat unit DC having a structure (II), and at least one repeat unit BC having a structure (III) or (V). The multicomponent copolymer may be cross-linked via a cross-linking agent. A polymer blend including the multicomponent copolymer or a cross-linked copolymer and a second polymer is also provided. The multicomponent copolymer may be a random or a block copolymer. The structural units of the multicomponent copolymers provide improved, tunable properties, such as improved biocompatibility and hydrophilicity, protein fouling, and mechanical properties, to the copolymers and/or the membranes fabricated from the copolymers.Type: ApplicationFiled: November 30, 2020Publication date: March 18, 2021Inventors: David Moore, Matthew Jeremiah Misner, Hongyi Zhou, Patrick McCloskey, Matthew Rainka
-
Publication number: 20210055282Abstract: A device for rapid detection of a tuberculosis lipoarabinomannan (TB-LAM) is provided. The device includes a pre-concentrator unit for concentrating the TB-LAM comprising: an ion-exchange medium comprising one or more ligands configured to capture the TB-LAM from the source biological sample, wherein the captured-TB-LAM is eluted from the ion-exchange medium as an eluate comprising a concentrated form of TB-LAM; a cassette; a lateral flow assay unit disposed in the cassette; and an integration unit attached to the pre-concentrator unit and the cassette. The integration unit is configured to operatively couple and de-couple the pre-concentrator unit and the cassette. The pre-concentrator unit and the lateral flow assay unit disposed in the cassette are in a fluidic communication in a coupled form. The device for rapid detection of TB-LAM further comprises a dilutor unit.Type: ApplicationFiled: November 6, 2020Publication date: February 25, 2021Inventors: Matthew Jeremiah Misner, Gregory Andrew Grossmann, Cathryn Ellen Olsen, John Richard Nelson, David Roger Moore, Paul Michael Smigelski, John Thomas Connelly, Benjamin David Grant, Bernhard Hans Weigl
-
Publication number: 20210055297Abstract: A rapid detection method of a target biomolecule comprising an antigenic moiety is provided. The method includes providing a source biological sample comprising the target biomolecule; contacting the source biological sample to an ion-exchange medium; eluting the captured-target biomolecule from the ion-exchange medium as an eluate, and loading the eluate to a rapid diagnostic testing device comprising an antibody. The eluate comprises a concentrated form of the biomolecule in a solution having a salt concentration greater than 150 mM. A concentration of the target biomolecule in the eluate is in a range from about 2× to 25× compared to a concentration of the biomolecule in the source biological sample. The target biomolecule binds to the antibody under the salt concentration of greater than 150 mM. A device for rapid detection of target biomolecule is also provided.Type: ApplicationFiled: November 5, 2020Publication date: February 25, 2021Inventors: Matthew Jeremiah Misner, Gregory Andrew Grossmann, Cathryn Ellen Olsen, John Richard Nelson, Brian Christopher Bales, David Roger Moore, Paul Michael Smigelski
-
Patent number: 10851241Abstract: Multicomponent copolymers including two or more types of repeat units is presented. In one example, the multicomponent copolymer includes at least one repeat unit AC having a structure (I), at least one repeat unit DC having a structure (II), and at least one repeat unit BC having a structure (III) or (V). The multicomponent copolymer may be cross-linked via a cross-linking agent. A polymer blend including the multicomponent copolymer or a cross-linked copolymer and a second polymer is also provided. The multicomponent copolymer may be a random or a block copolymer. The structural units of the multicomponent copolymers provide improved, tunable properties, such as improved biocompatibility and hydrophilicity, protein fouling, and mechanical properties, to the copolymers and/or the membranes fabricated from the copolymers.Type: GrantFiled: May 15, 2018Date of Patent: December 1, 2020Assignee: Cytiva Sweden ABInventors: David Moore, Matthew Jeremiah Misner, Hongyi Zhou, Patrick McCloskey, Matthew Rainka
-
Patent number: 10837962Abstract: A rapid detection method of a target biomolecule comprising an antigenic moiety is provided. The method includes providing a source biological sample comprising the target biomolecule; contacting the source biological sample to an ion-exchange medium; eluting the captured-target biomolecule from the ion-exchange medium as an eluate, and loading the eluate to a rapid diagnostic testing device comprising an antibody. The eluate comprises a concentrated form of the biomolecule in a solution having a salt concentration greater than 150 mM. A concentration of the target biomolecule in the eluate is in a range from about 2× to 25× compared to a concentration of the biomolecule in the source biological sample. The target biomolecule binds to the antibody under the salt concentration of greater than 150 mM. A device for rapid detection of target biomolecule is also provided.Type: GrantFiled: December 20, 2017Date of Patent: November 17, 2020Assignee: GENERAL ELECTRIC COMPANYInventors: Matthew Jeremiah Misner, Gregory Andrew Grossmann, Cathryn Ellen Olsen, John Richard Nelson, Brian Christopher Bales, David Roger Moore, Paul Michael Smigelski, Jr.
-
Patent number: 10830760Abstract: A device for rapid detection of a tuberculosis lipoarabinomannan (TB-LAM) is provided. The device includes a pre-concentrator unit for concentrating the TB-LAM comprising: an ion-exchange medium comprising one or more ligands configured to capture the TB-LAM from the source biological sample, wherein the captured-TB-LAM is eluted from the ion-exchange medium as an eluate comprising a concentrated form of TB-LAM; a cassette; a lateral flow assay unit disposed in the cassette; and an integration unit attached to the pre-concentrator unit and the cassette. The integration unit is configured to operatively couple and de-couple the pre-concentrator unit and the cassette. The pre-concentrator unit and the lateral flow assay unit disposed in the cassette are in a fluidic communication in a coupled form. The device for rapid detection of TB-LAM further comprises a dilutor unit.Type: GrantFiled: December 20, 2017Date of Patent: November 10, 2020Assignee: GENERAL ELECTRIC COMPANYInventors: Matthew Jeremiah Misner, Gregory Andrew Grossmann, Cathryn Ellen Olsen, John Richard Nelson, David Roger Moore, Paul Michael Smigelski, Jr., John Thomas Connelly, Benjamin David Grant, Bernhard Hans Weigl
-
Publication number: 20200107758Abstract: The systems and methods described herein provide a wearable sweat sensing device. The device includes a sweat patch component including a sweat biochemical sensor patch having a substrate defining a hole, at least one biochemical sensor, and a capture wick including a tip that extends through the hole, the capture wick configured to channel sweat across the at least one biochemical sensor. The sweat patch component further includes a wick downstream from the capture wick and separated from the capture wick by a gap, and electronic circuitry disposed against at least one face of the wick, wherein an electronic response of the electronic circuitry changes as sweat flows through the wick. The wearable sweat sensing device further includes an electronics module component configured to facilitate assessing hydration of a wearer based on signals from the at least one biochemical sensor and the electronic circuitry.Type: ApplicationFiled: June 17, 2019Publication date: April 9, 2020Inventors: Ralf Lenigk, Azar Alizadeh, Matthew Jeremiah Misner, Andrew Arthur Paul Burns, Richard JeanLuc St. Pierre
-
Publication number: 20200080047Abstract: A system for isolating a target molecule from a bioprocess fluid includes a single-use disposable separation device having a plurality of perimeter-bonded layers defining one or more mesofluidic channels of the separation device, wherein each layer includes a biocompatible polymer material, wherein the separation device is configured to separate at least a portion of particles from the bioprocess fluid to generate a substantially clarified bioprocess fluid, and a chromatography system fluidically coupled at the outflow of the separation device in a configuration for further processing the clarified bioprocess fluid.Type: ApplicationFiled: September 11, 2018Publication date: March 12, 2020Inventors: Matthew Jeremiah Misner, Rachel Marie Gettings, Christine Angela Morton, Erik Leeming Kvam, Jason William Castle, Anindya Kanti De, Jared Timothy Hale, Craig Patrick Galligan, Vincent Francis Pizzi
-
Patent number: 10518227Abstract: A membrane including a block copolymer is presented. The block copolymer includes at least one block A including structural units having a formula (I), and at least one block B including structural units having a formula (II). A hollow-fiber membrane for hemodialysis or hemofiltration, and associated block copolymer are also presented.Type: GrantFiled: May 12, 2015Date of Patent: December 31, 2019Assignee: GENERAL ELECTRIC COMPANYInventors: Patrick Joseph McCloskey, Julia Lam Lee, David Roger Moore, Cathryn Ellen Olsen, Matthew Jeremiah Misner, Louisa Ruth Carr, Hongyi Zhou